Article
Bioanalytical methods, strategies and outlook for antibody-drug conjugate trials (Chinese)
![](https://content.labcorp.com/sites/default/files/biopharma_knowledge_library/whitepapers/824504_WP_ADC_Chinese_FINAL.pdf.png)
Antibody-drug conjugates (ADCs) are formed by antibodies targeting a specific antigen or antibody fragment covalently attached to payloads (such as small molecule cytotoxic drugs) via a linker. The primary goal of ADCs is to target the payload to specific sites through the antibody, combining the potent cytotoxic effects of traditional small molecule drugs with the tumor-targeting characteristics of antibody drugs. Version: Chinese Language